Identifying, monitoring, and treating women for breast precancer or cancer
US6642010B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2000 |
| Grant date | Nov 4, 2003 |
| Priority date | — |
| Expiry date | Feb 18, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/723
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is to methods for screening women for breast cancer and precancer by determining a level of an estrogen-related marker. The invention further provides methods of treating such patients identified as having one or more abnormal ductal epithelial cells and an estrogen-related marker. The invention provides methods for screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT. The invention provides methods of treating peri-, menopausal or postmenopausal women for both cancer risk reduction and menopausal symptoms (or other conditions related to lowered systemic estrogen levels). The invention also provides kits for the screening, monitoring, and treating methods described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.